NCT01984723View on ClinicalTrials.gov

EVP-6124 Renal Impairment Study

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2014

Conditions
Renal Impairment
Interventions
DRUG

Experimental: EVP-6124

Trial Locations (2)

Unknown

Jankovcova 1569/2c, 17000 Praha 7

Rottenbiller U. 13 H-1077 Budapest

Sponsors

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

FORUM Pharmaceuticals Inc

INDUSTRY